The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The House Dust Mite Allergy Market In 2026 And 2030?
The house dust mite allergy market has experienced considerable expansion in recent years. It is forecast to grow from $2.37 billion in 2025 to $2.7 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this growth was influenced by factors such as the escalating prevalence of allergic conditions, enhanced public awareness regarding respiratory allergies, broadened availability of diagnostic tests, increased usage of antihistamine medications, and advancements in allergy treatment protocols.
The market for house dust mite allergy treatments is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this growth during the projected period include the rising acceptance of individualized immunotherapy, a heightened emphasis on proactive allergy prevention, the broader availability of home-based allergy solutions, an increasing need for sustained symptom management, and breakthroughs in biologic treatments for allergies. Key trends observed within this forecast timeframe encompass the wider integration of immunotherapy-driven treatments, the increasing popularity of sublingual allergy tablets, a greater desire for enduring allergy management options, the expanded uptake of early diagnostic tests, and a stronger emphasis on tailored allergy interventions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp
What Primary Drivers Are Shaping The House Dust Mite Allergy Market?
The increasing occurrence of asthma conditions is projected to drive the expansion of the house dust mite allergy market in the future. Asthma diseases are defined as chronic inflammatory airway disorders characterized by recurring episodes of breathlessness, wheezing, chest tightness, and coughing. The rise in asthma diseases is attributed to growing environmental pollution, which intensifies airway inflammation and heightens sensitivity to allergens. The house dust mite allergy market is experiencing heightened demand as the rapid spread of asthma diseases motivates companies to adopt solutions that reduce allergen exposure and support improved respiratory health outcomes. For instance, in June 2025, according to the American Lung Association, a US-based nonprofit health organization, current asthma prevalence among adults demonstrated significant variation across US jurisdictions, ranging from 7.1% in Mississippi to 14.1% in Puerto Rico in 2023. Thus, the prevalence of asthma diseases is stimulating the demand for the house dust mite allergy market.
How Is The House Dust Mite Allergy Market Organized By Segment Classification?
The house dust mite allergy market covered in this report is segmented –
1) By Product Type: Tablets, Nasal Drops, Injectable
2) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
3) By Dosage Forms: Solid, Liquid
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Tablets: Sublingual Tablets, Oral Tablets
2) By Nasal Drops: Antihistamine Nasal Drops, Corticosteroid Nasal Drops
3) By Injectable: Allergen Immunotherapy Injections, Corticosteroid Injections
What Trends Are Affecting The Growth Of The House Dust Mite Allergy Market?
Major companies in the house dust mite allergy market are focusing on developing innovative solutions, such as sublingual tablets designed to treat house dust mite allergies, to address the increasing prevalence of allergies. A sublingual tablet designed to treat house dust mite allergies represents a type of immunotherapy where a tablet is placed under the tongue, dissolves, and delivers small doses of the allergen responsible for triggering the allergy. For instance, ALK-Abelló A/S, a Denmark-based pharmaceutical company, obtained FDA approval in January 2023 for ODACTRA, a sublingual tablet aimed at treating house dust mite allergies in adolescents aged 12 to 17, extending its prior indication for adults. This approval meets a significant need, as nearly 50% of allergy sufferers are sensitive to house dust mites. Clinical trials demonstrated ODACTRA’s effectiveness in reducing allergy symptoms, showing a safety profile similar to that observed in adults. While the treatment is generally well-tolerated, patients are advised to have auto-injectable epinephrine on hand due to the potential for severe allergic reactions.
Who Are The Industry Participants Involved In The House Dust Mite Allergy Market?
Major companies operating in the house dust mite allergy market are Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline
Get The Full House Dust Mite Allergy Market Report:
https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report
Which Region Represents The Largest Share Of The House Dust Mite Allergy Market?
North America was the largest region in the house dust mite allergy market in 2025. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized House Dust Mite Allergy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=9304&type=smp
Browse Through More Reports Similar to the Global House Dust Mite Allergy Market 2026, By The Business Research Company
Allergy Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report
Allergy Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report
Allergy Immunotherapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model